We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Bacteria-Based Biosensor Detects Zinc Deficiency

By LabMedica International staff writers
Posted on 14 Sep 2015
A series of genetic engineering steps led to the development of a bacterial biosensor capable of visually distinguishing levels of zinc, a critical micronutrient.

Micronutrient deficiencies, including zinc deficiency, are responsible for hundreds of thousands of deaths annually. A key obstacle to allocating scarce treatment resources is the ability to measure population blood micronutrient status inexpensively and quickly enough to identify those who most need treatment.

To overcome this obstacle a team of molecular microbiologists at the Georgia Institute of Technology (Atlanta, USA) developed a novel approach for inexpensive screening of micronutrients, with zinc being the test case.

Towards this end, the investigators genetically engineered a strain of Escherichia coli to produce different colored pigments (violacein, lycopene, and beta-carotene) in response to different extracellular zinc levels. Genes for the pigments were taken from other organisms and inserted into the E. coli on a plasmid. The red and orange colors, lycopene and beta-carotene, were produced by genes taken from Pantoea anantis, a plant pathogen. The purple color, violacein, came from a soil bacterium.

Obtaining discrete color states in the carotenoid pathway required precise engineering of the E. coli's metabolism to prevent a reaction at low zinc concentrations but allow complete reaction at higher concentrations, and all under the constraints of the bacterium's natural regulator limitations. A combination of gene dosage, post-transcriptional, and post-translational regulation was necessary to allow visible color change over physiologically relevant ranges representing a small fraction of the regulator’s dynamic response range, with further tuning possible by modulation of precursor availability.

In practice, a pellet of the engineered bacteria was mixed with the plasma from a human subject. The E. coli multiplied, producing the color corresponding to the level of zinc in the sample. Purple corresponded to dangerously low levels, while red indicated borderline levels, and orange normal levels. The color was readily visible without any diagnostic or other electronic equipment.

"We think this is just enough technology to meet the needs," said Dr. Mark Styczynski, assistant professor of chemical and bio-molecular engineering at the Georgia Institute of Technology. "Information we can provide could one day help nutritional epidemiologists and non-governmental organizations determine the populations of people that may need interventions to address nutritional deficiencies."

"The general idea of bio-sensing is certainly out there, but we have taken the step of developing a system that does not require equipment in the field," said Dr. Styczynski. "We believe this will work well in low-resource areas. This is a convincing proof-of-principle, and we hope to begin the translational aspects of this system based on what we have already shown. It is a matter now of reducing this to practice for something that will ultimately be useful."

The novel assay for zinc deficiency was described in a paper published in the September 2015 issue of the journal Metabolic Engineering.

Related Links:

Georgia Institute of Technology



Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Urine Drug Test
Instant-view Propoxyphene Urine Drug Test
New
Treponema Pallidum Test
ZEUS IFA Fluorescent Treponemal Antibody-Absorption (FTA-ABS) Test System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: RT-QuIC Prion, CSF is the only definitive antemortem clinical test of its kind that doesn’t involve a brain biopsy (Photo courtesy of Mayo Clinic)

CSF Test Distinguishes Prion Disease from Other Causes of Rapidly Progressive Dementia

Rapidly progressive dementias are a category of dementia where patients experience a swift decline from the onset of symptoms to losing functional independence, typically within two years.... Read more

Immunology

view channel
Image: New insights into preterm infant immunity could inform care (Photo courtesy of 123RF)

New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood

Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more

Pathology

view channel
Image: The Results Manager System (Photo courtesy of QuidelOrtho)

Informatics Solution Elevates Laboratory Efficiency and Patient Care

QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.